Private Equity 3 Days

Last updated: May 15, 2026, 2:31 PM ET

Deal Activity & Consolidation Tecomet‑Orchid merger created a combined orthopedics platform under the Tecomet name, expanding the Nordic‑backed Orchid’s footprint in Europe and adding roughly €150 million of annual revenue to the enlarged entity. In the United States, Kinderhook’s take‑private of Enhabit transferred ownership of the home‑health and hospice provider to the private‑equity sponsor, positioning Kinderhook to roll‑up fragmented post‑acute assets and leverage Enhabit’s $1.2 billion revenue base. Across the Atlantic, HIG Capital’s acquisition of International Aerospace Coatings gave the fund a niche supplier to OEMs and MRO operators, a sector where demand is buoyed by rising aircraft utilization rates post‑pandemic.

Sector‑Specific Targeting A wave of interest in life‑science services surfaced as Blackstone, Audax and Five Arrows scouted pharma consulting firms, citing the “drug‑R&D complexity” that fuels demand for specialized advisory platforms. Parallel to that, Eir Partners’ investment in QuartzBio underscored the appeal of data‑analytics tools that accelerate biomarker discovery, while Fusion Capital‑backed Relevant’s purchase of Automation Werx added flow‑control expertise to a portfolio focused on industrial automation, reflecting a broader private‑equity thrust into high‑margin, technology‑enabled services.

Strategic Exits & Fund Deployments Schroders’ exit from its China fund unit transferred a suite of on‑shore products to Neuberger Berman, marking a rare retreat from direct China fund management amid regulatory headwinds and allowing Schroders to redeploy capital into core markets. Meanwhile, CPP Investments’ €400 million co‑investment with Blackstone in French logistics platform Proudreed signaled sovereign wealth’s appetite for last‑mile delivery assets as e‑commerce volumes stay elevated. In the consumer arena, L Catterton’s stake in Saint Bella provided the LVMH‑linked firm with a foothold in China’s burgeoning family‑care segment, leveraging Saint Bella’s “global family‑care” strategy to capture rising disposable income.

High‑Profile Take‑Private Bids Blackstone and CD&R’s evaluation of Magnum Ice Cream came as the listed brand traded below its 2022 IPO price, prompting bidders to consider a leveraged recapitalisation that could unlock value through brand‑level cost efficiencies. A more aggressive restructuring unfolded when Blackstone and KKR‑led lenders cut Affordable Care’s debt by roughly 70%, effectively handing the consortium control of the senior‑care operator and illustrating how deep‑discount debt restructurings can generate equity upside in distressed healthcare assets. The same week, Blackstone’s record‑size $1.75 billion blind‑pool REIT IPO raised capital to pursue AI‑driven data‑centre acquisitions, highlighting the firm’s pivot toward infrastructure that supports generative‑AI workloads.

Fundraising Momentum & Future Outlook Blackstone’s preparation for a third long‑hold buyout fund reflects confidence that “long‑duration” capital will remain scarce, with the firm targeting $20 billion of commitments to back multi‑year hold strategies across North America and Europe. Complementing that, CPP Investments’ €400 million co‑invest in Proudreed and Blackstone’s €600 million drone‑maker round with Airbus illustrate how institutional capital is being marshalled into niche technology and logistics platforms that promise recurring cash flows. Collectively, these moves suggest private‑equity sponsors are deepening sector specialization, leveraging distressed‑asset opportunities, and securing capital for long‑term, high‑growth investments as market volatility persists.